Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxytropis falcata Bunge is a perennial, stemless herb traditionally used in Tibetan and Chinese medicine. It is widely recognized for its **anti-inflammatory**, **analgesic**, **antioxidant**, **antibacterial**, **hemostatic**, and **antitumor** properties. OF is used clinically for conditions such as **fever**, **pain**, **rheumatoid arthritis**, and **eczema**, and is an active component in formulations like Qingpeng Ointment and Qizheng Xiaotong plaster. Key pharmacologically active compounds are **flavonoids**, including isoflavones (e.g., daidzein, maackiain), flavones (e.g., 7-hydroxyflavone, luteolin), naringenin, and chalcones. Mechanistic studies show that extracts of this plant can inhibit proinflammatory cytokine release and downregulate pathways such as HDAC3/NF-κB and JAK1/STAT1, contributing to reduced inflammation and tissue injury in models of atopic dermatitis and pulmonary fibrosis. Additionally, it upregulates SOCS3, an inhibitor of cytokine signaling[1][2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxytropis falcata bunge.